Back to top

Intellia Therapeutics Welcomes New Principal Accounting Officer

Intellia Therapeutics (NTLA) has provided an update. Intellia Therapeutics has appointed Michael P. Dube as the new principal accounting officer. W...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Intellia Therapeutics, Inc. (NTLA)